Polyrizon (NASDAQ:PLRZ) Issues Quarterly Earnings Results

Polyrizon (NASDAQ:PLRZ) announced its quarterly earnings data on Wednesday. The company reported $2.81 EPS for the quarter, FiscalAI reports.

Polyrizon Trading Up 4.8%

PLRZ opened at $14.23 on Thursday. The firm has a 50-day moving average price of $13.93 and a 200-day moving average price of $9.76. Polyrizon has a twelve month low of $2.88 and a twelve month high of $2,235.00.

Hedge Funds Weigh In On Polyrizon

An institutional investor recently bought a new position in Polyrizon stock. Jane Street Group LLC bought a new position in Polyrizon Ltd. (NASDAQ:PLRZ) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned approximately 1.35% of Polyrizon at the end of the most recent reporting period.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Polyrizon in a research note on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.